NCT05826574View on ClinicalTrials.gov

A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

May 10, 2023

Primary Completion Date

July 16, 2023

Study Completion Date

July 16, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

Brensocatib

Oral tablets.

DRUG

Rifampin

Oral capsules.

DRUG

Esomeprazole

Oral capsules.

Trial Locations (1)

75247

USA001, Dallas

All Listed Sponsors

lead

Insmed Incorporated

INDUSTRY